These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16027807)

  • 21. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [THE INFLUENCE OF MEXIDOL AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE ON LIPOFUSCINE CONTENT IN RAT BRAIN UNDER LOCAL PERMANENT ISCHEMIA CONDITIONS].
    Mirzoyan NR; Bagdasaryan NA; Alikhanyan CB; Meliksetyan VS; Bagdasaryan MG; Kukhtarova AM
    Eksp Klin Farmakol; 2015; 78(8):3-6. PubMed ID: 26591573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of mexidol in carotid endarterectomy procedure in patients with cerebral atherosclerotic stenosis].
    Golovkin VI; Svetlikov AV; Shapovalov AS; Popova LO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):51-55. PubMed ID: 26977626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analgesic effect of succinate-containing preparations].
    Iasnetsov VV; Prosvirova EP; Motin VG; Karsanova SK; Chel'naia NA; Iasnetsov VV
    Eksp Klin Farmakol; 2013; 76(4):11-4. PubMed ID: 23762982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of mexidol on the course of post-traumatic epilepsy].
    Novikov VE; Maslova NN
    Eksp Klin Farmakol; 2003; 66(4):9-11. PubMed ID: 14558343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental substantiation for the use of mexidol and 3-hydroxypyridine fumarate in chronic myocardial injury.
    Zamotaeva MN; Chairkin IN; Inchina VI; Drozdov IA
    Bull Exp Biol Med; 2013 Jun; 155(2):212-3. PubMed ID: 24130992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children].
    Levitina EV
    Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effects of mexidol in pain syndromes].
    Danilova ED; Grafova VN; Voronina TA; Reshetniak VK
    Eksp Klin Farmakol; 1995; 58(3):17-20. PubMed ID: 7663286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of mexidol on the magnitude of a systemic inflammatory response in patients at aortocoronary bypass surgery].
    Eremenko AA; Ziuliaeva TP; Egorov VM; Sidorenko IaV; Fominykh MV
    Anesteziol Reanimatol; 2008; (4):27-30. PubMed ID: 18819391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
    Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
    Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ; Zaharov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
    Duma SN
    Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mexidol potentiates antiparkinsonian effect of L-DOPA in MPTP-induced parkinsonism model].
    Kucherianu VG
    Eksp Klin Farmakol; 2001; 64(1):22-5. PubMed ID: 11544797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of mexidol on the homeostasis and lipid peroxidation in paracetamol poisoning].
    Katikova OIu
    Eksp Klin Farmakol; 2002; 65(6):53-6. PubMed ID: 12596535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of mexidol on the development of the phenomenon of the neuronal excitotoxicity in vitro].
    Shchul'kin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):35-9. PubMed ID: 22677663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mexidol: the spectrum of pharmacological effects].
    Voronina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):86-90. PubMed ID: 23461005
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effects of Mexidol on food conditioning and synaptic fine structure of hippocampal field CA1 in rats exposed to a single acoustic stimulation with ultrasonic components].
    Alekseeva TG; Loseva EV; Mering TA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(2):269-76. PubMed ID: 15174273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative antioxidant and antihypoxic activities of new 1,4-dihydro-4-oxopyrimidine derivative--compound PDMpT.HCl and mexidol].
    Petrova EV; Oganesian ÉT; Kodonidi IP; Zhoglo EN
    Eksp Klin Farmakol; 2013; 76(6):38-40. PubMed ID: 24003490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of mexidol in stomatology: results and perspectives].
    Petrovich IuA; Sukhova TV; Lemetskaia TI
    Stomatologiia (Mosk); 2004; 83(6):17-22. PubMed ID: 15609456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.